Joshua J Neumiller
Overview
Explore the profile of Joshua J Neumiller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
114
Citations
2577
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Munshi M, Kahkoska A, Neumiller J, Alexopoulos A, Allen N, Cukierman-Yaffe T, et al.
Lancet Diabetes Endocrinol
. 2025 Feb;
PMID: 39978368
Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ability to perform self-care. Most diabetes guidelines focus on improving glycaemia through addition...
3.
Neumiller J
Diabetes Spectr
. 2025 Feb;
38(1):115-120.
PMID: 39959525
This article is adapted from the address Dr. Neumiller delivered as the recipient of the American Diabetes Association's Outstanding Educator in Diabetes Award for 2024. He delivered the address in...
4.
Alicic R, Neumiller J, Tuttle K
Nephrol Dial Transplant
. 2025 Feb;
40(Supplement_1):i3-i17.
PMID: 39907543
Abstract: The global burden of chronic kidney disease (CKD) increased by nearly 90% in the period spanning 1990 to 2016, mostly attributed to an increase in the prevalence of CKD...
5.
McCoy R, Swarna K, Neumiller J, Polley E, Deng Y, Mickelson M, et al.
Clin Diabetes
. 2025 Jan;
43(1):59-70.
PMID: 39829688
In this emulated comparative effectiveness target trial of glucagon-like peptide 1 (GLP-1) receptor agonist, sodium-glucose cotransporter 2 (SGLT2) inhibitor, dipeptidyl peptidase 4 (DPP-4) inhibitor, and sulfonylurea therapy among adults with...
6.
Neumiller J, Herrin J, Swarna K, Polley E, Galindo R, Umpierrez G, et al.
Clin J Am Soc Nephrol
. 2024 Dec;
PMID: 39729347
No abstract available.
7.
Neumiller J, Bajaj M, Bannuru R, McCoy R, Pekas E, Segal A, et al.
Diabetes Care
. 2024 Dec;
48(2):177-181.
PMID: 39620926
The use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) and dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 RA (GIP/GLP-1 RA) classes has increased substantially over the past several years...
8.
Rhee C, Gianchandani R, Kerr D, Philis-Tsimikas A, Kovesdy C, Stanton R, et al.
J Diabetes Sci Technol
. 2024 Nov;
19(1):217-245.
PMID: 39611379
This report represents the conclusions of 15 experts in nephrology and endocrinology, based on their knowledge of key studies and evidence in the field, on the role of continuous glucose...
9.
St Peter W, Bzowyckyj A, Anderson-Haag T, Awdishu L, Blackman M, Bland A, et al.
Am J Health Syst Pharm
. 2024 Nov;
PMID: 39552516
Purpose: The goals of this paper are to (1) provide evidence and expert consensus to support a unified approach to estimating kidney filtration in adults with stable kidney function using...
10.
Whitley H, Trujillo J, Neumiller J
Clin Diabetes
. 2024 Oct;
42(4):583.
PMID: 39429459
[This corrects the article DOI: 10.2337/cd23-0023.].